Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 7501

A Camcopter S-100 drone made the first commercial drone delivery to an offshore oil platform in late August and it might be the beginning of a major industry. The helicopter drone flew a 3D printed part from Norway to a rig located about 60 miles off the coast. The flight was conducted without any special airspace adjustments and the drone was just part of the traffic servicing the oil fields. The drone also did an exterior inspection of the drilling platform and performed a simulated search and rescue drill with the rig’s standby vessel.

Of course, the oil companies are keeping a close eye on the drone developments because hauling freight and supplies to the rigs by drone could not only be a lot cheaper, but also safer. There are also several major helicopter companies that have oilfield supply as their core business watching the new initiatives. Servicing oil platforms is a multibillion-dollar business and also one of the most dangerous forms of commercial flying. Nordic Unmanned, which flew the first drone flight, says drones are a viable alternative to many missions now flown by big, expensive helicopters. “This marks the beginning of a new chapter within unmanned logistics,” spokesman Pål Kristensen said.” The technology is proven and robust enough to implement in large scale and reduces the risk cost and environmental footprint drastically.”

Read more | >

Methods: In this review, due to their promise, we focus on inorganic nanomaterials [such as hollow mesoporous silica nanoparticles (HMSNs), tungsten sulfide quantum dots (WS2QDs), and gold nanorods (AuNRs)] combining PTT with CHT, RT or IT in one treatment, aiming to provide a comprehensive understanding of PTT-based combinational cancer therapy. Results: This review found much evidence for the use of inorganic nanoparticles for PTT-based combinational cancer therapy. Conclusion: Under synergistic effects, inorganic nanomaterial-based combinational treatments exhibit enhanced therapeutic effects compared to PTT, CHT, RT, IT or PDT alone and should be further investigated in the cancer field.

Applications of inorganic nanomaterials in photothermal therapy based on combinational cancer treatment — pubmed.

Read more | >

Public-private partnerships have been central to the development of cybersecurity over the past decade, through the sharing of threat information between commercial organizations and historically secretive government agencies. The opportunity now exists for a new era of public-private partnership, for a new realm of information sharing.

Cyberattacks continue to be reported as a key business risk. In the recent World Economic Forum’s Regional Risks for Doing Business 2019 report, survey respondents in six of the world’s 10-largest economies identified cyberattacks as their number one risk.

However, as distinct from other risks such as fiscal crises or energy price shocks, cyberattacks have a clear mitigation: cybersecurity. Yet despite a decade of rising spending, respondents do not have confidence in their ability to deliver sufficiently strong cybersecurity to mitigate the risk. Why is this?

Continue reading “How to build a modern public-private cybersecurity partnership” | >

With two successful 150-meter hops in the bag for SpaceX, Starship testing is preparing to enter the next phase. Starship SN6’s successful 150-meter hop followed just weeks after SN5’s achievement.

While SN5 is preparing to conduct another leap, Starship SN8 is closing in on its maiden flight, this time sporting three Raptor engines, a nosecone, and aero surfaces – likely to come after additional data is gathered via the upcoming SN7.1 Test Tank “Burst Test.”

Read more | >

Research carried out by a University academic has shed new light on the fundamentals of how, and why, we make the decisions we do.

In two separate studies, UKRI Future Leader Fellow and Lecturer in Psychology, Dr. Elsa Fouragnan has used her expertise in imaging (fMRI) and to discover exactly what happens in the brains of human and non-human primates when certain kinds of decisions are made in different contexts. Both pieces of work were carried out in collaboration with researchers at the University of Oxford’s Department of Experimental Psychology.

The first, published in Nature Communications, explores how and where the encodes a memory of the general rate in an environment, what the team describes as the ‘richness’ of the context in which decisions are made.

Read more | >

Since antiquity, cultures on nearly every continent have discovered that certain plant leaves, when chewed or brewed or rubbed on the body, could relieve diverse ailments, inspire hallucinations or, in higher dosages, even cause death. Today, pharmaceutical companies import these once-rare plants from specialized farms and extract their active chemical compounds to make drugs like scopolamine for relieving motion sickness and postoperative nausea, and atropine, to curb the drooling associated with Parkinson’s disease or help maintain cardiac function when intubating COVID-19 patients and placing them on ventilators.

Now, Stanford engineers are recreating these ancient remedies in a thoroughly modern way by genetically reprogramming the cellular machinery of a special strain of yeast, effectively transforming them into microscopic factories that convert sugars and amino acids into these folkloric drugs, in much the same way that brewers’ yeast can naturally convert sugars into alcohol.

Read more | >